Status:
SUSPENDED
Non-endoscopic EC Screening Program in Northern Iran
Lead Sponsor:
Tehran University of Medical Sciences
Collaborating Sponsors:
International Agency for Research on Cancer
University of Cambridge
Conditions:
Esophageal Cancer
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The aim of this study is to assess the effects of implementation of a non-endoscopic esophageal cancer-screening program on outcomes of interest in an asymptomatic high-risk population in Golestan Pro...
Detailed Description
Background: Esophageal cancer (EC) is the 8th most common cancer and the 6th most common cause of death from cancer worldwide. Golestan province located in Northern Iran has been known as a high-risk...
Eligibility Criteria
Inclusion
- Participants of Golestan Cohort study with age higher than 50 years.
Exclusion
- Subjects with a history of malignant disease, liver cirrhosis, or chronic renal failure will be excluded.
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT02311712
Start Date
December 1 2016
End Date
December 1 2029
Last Update
April 16 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.